LobbyingThe National Alliance for Eye and Vision Research lobbying by quarter
The National Alliance for Eye and Vision Research's latest lobbying report covers Q1 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $20K. Its first report covers Q1 2022; the issues it reports most are Budget/Appropriations and Defense.
The National Alliance for Eye and Vision Research
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $20K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2022 | $64.4K | 1 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $63.9K | 1 |
| Q1 2023 | $46.1K | 1 |
| Q2 2023 | $48.8K | 1 |
| Q3 2023 | $46.8K | 1 |
| Q4 2023 | $45K | 1 |
| Q1 2024 | $24.6K | 1 |
| Q2 2024 | $35.9K | 1 |
| Q3 2024 | $28.8K | 1 |
| Q4 2024 | $23.9K | 1 |
| Q1 2025 | $32.5K | 1 |
| Q2 2025 | $34K | 1 |
| Q3 2025 | $31K | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $20K | 1 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$142.3K · 14 reports
- Defense$132.3K · 13 reports
- Veterans$110.7K · 11 reports
- Medical research and clinical labs$96.6K · 9 reports
- Health issues$63.6K · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseThe National Alliance for Eye and Vision Research | $545.5K | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 04/08for Q1 | In-house | $20K |
| 25/11/24for Q3 2024 | In-house | $28.8K |
| 25/11/24for Q3 2025 | In-house | $31K |
| 25/11/24for Q2 2025 | In-house | $34K |
| 25/11/24for Q1 2025 | In-house | $32.5K |
| 25/01/14for Q4 2024 | In-house | $23.9K |
| 25/01/14for Q4 2024 | In-house | $28.8K |
| 24/08/12for Q2 2024 | In-house | $35.9K |
| 24/06/25for Q1 2024 | In-house | $24.6K |
| 24/02/06for Q4 2023 | In-house | $45K |
| 23/10/26for Q3 2023 | In-house | $46.8K |
| 23/10/20for Q1 2022 | In-house | $64.4K |
| 23/07/25for Q2 2023 | In-house | $48.8K |
| 23/05/01for Q1 2023 | In-house | $46.1K |
| 23/01/23for Q4 2022 | In-house | $63.9K |